Track topics on Twitter Track topics that are important to you
In the year 2016, the European biopsy device market accounted for $616 million. The market is now anticipated to show a CAGR growth of 5.97% for the forecast period of 20172025. This exceptional growth can be attributed to the recurrent cash flow from biopsy procedures, growing centers for diagnosis, a surge in elderly population and the various government programs.
The Europe biopsy market is classified into the following segments. The end users segment comprise of general or specialty hospitals, diagnostics centers, etc; the device type segment comprises of bronchial biopsy, gynecological biopsy device, robotic guidance system, soft tissue needles and breast biopsy vacuum assisted core biopsy VAB, core needle biopsy CNB, fine needle biopsy, etc. The display technologies segment includes CT guided biopsy, ultrasound guided biopsy, stereotactic guided biopsy, MRI guided biopsy, ultrasound guided biopsy, and other display technologies. And, the therapeutic area segment comprises of biopsies for prostate, liver, lung, kidney, breast, gynecology etc.Although the segmentation is wide, the infection risks associated with breast biopsy techniques and the concerns related to regulation might restrain the market growth in the coming years.
The prominent companies in the market include Fischer Medical Technologies LLC, Cook Group INC, C. R. Bard, Inc, Becton Dickinson Company, and B. Braun Melsungen AG.
Track and monitor developments in breast cancer research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...